CORDIS
EU research results

CORDIS

English EN
ERA-NET on Translational Cancer Research

ERA-NET on Translational Cancer Research

Objective

Cancer is a worldwide health burden and a major public health challenge in Europe, responsible for 25% of all deaths; a situation expected to worsen with population ageing. The strengthening of translational cancer research is an urgent need in European cancer research, i.e. the integration of basic, epidemiological, preclinical and clinical research with the implementation and evaluation of interventions in prevention, diagnosis, prognosis, treatment and care.
The proposed ERA-NET TRANSCAN aims at linking translational cancer research funding programmes in 19 Member States and Associated Countries. By concentrating transnational resources TRANSCAN will provide a critical financial and scientific mass for tackling large scale problems, relevant for improving translational cancer research in each Member State or Associated Country as well as overall in Europe.
The objectives of TRANSCAN will be achieved through interconnected activities, structured into six work packages (WP) and facilitated by the project coordination and management (WP1). A survey and analysis of national cancer research funding (WP2) will provide a comprehensive picture of the nature and extent of translational cancer research funding in the EU. Based on this knowledge, TRANSCAN will identify gaps in and opportunities for coordinated translational research, and will thus contribute to the development of a coordinated funding research policy shared by European countries. Based also on the outcome of these activities, three joint transnational calls for multinational translational cancer research programmes will be designed (WP3) and implemented (WP4). In this context, training programmes/activities of multi-disciplinary translational cancer research teams will be supported (WP5). The TRANSCAN performance will be monitored and confronted with the partners’ expectations, and a sustainability plan for the network beyond TRANSCAN will be elaborated (WP6), contributing to the building of a pan-European platform for translational cancer research.

Coordinator

MINISTERO DELLA SALUTE

Address

Via Giorgio Ribotta 5
00144 Roma

Italy

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

EU Contribution

€ 207 825

Administrative Contact

Massimo Casciello (Dr.)

Participants (28)

Sort alphabetically

Sort by EU Contribution

Expand all

MINISTRSTVO ZA VISOKO SOLSTVO, ZNANOST IN TEHNOLOGIJO

Slovenia

EU Contribution

€ 41 730

ISTITUTO SUPERIORE DI SANITA

Italy

EU Contribution

€ 396 700

FONDS ZUR FÖRDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG

Austria

EU Contribution

€ 24 624

MASARYKUV ONKOLOGICKY USTAV

Czechia

EU Contribution

€ 6 712

INSTITUT NATIONAL DU CANCER GIP

France

EU Contribution

€ 269 907

BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG

Germany

DLR

Germany

EU Contribution

€ 300 357

GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS

Greece

EU Contribution

€ 28 890

KENTROU ELEGHOU & PROLIPSIS NOSIMATON

Greece

EU Contribution

€ 30 805

Orszagos Onkologiai Intezet

Hungary

EU Contribution

€ 19 527

MINISTRY OF HEALTH

Israel

EU Contribution

€ 15 247

ALLEANZA CONTRO IL CANCRO

Italy

EU Contribution

€ 115 560

MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA

Italy

EU Contribution

€ 7 000

REGIONE LIGURIA

Italy

LATVIJAS ZINATNU AKADEMIJA

Latvia

EU Contribution

€ 33 170

ZORGONDERZOEK NEDERLAND ZON

Netherlands

EU Contribution

€ 78 377

NORGES FORSKNINGSRAD

Norway

EU Contribution

€ 31 256

NARODOWE CENTRUM BADAN I ROZWOJU

Poland

EU Contribution

€ 16 852

FUNDACAO PARA A CIENCIA E A TECNOLOGIA

Portugal

EU Contribution

€ 43 870

INSTITUTUL ONCOLOGIC PROF. DR. ALEXANDRU TRESTIOREANU BUCURESTI

Romania

EU Contribution

€ 15 515

SLOVENSKA AKADEMIA VIED

Slovakia

EU Contribution

€ 26 897

Ministrstvo za izobrazevanje, znanost in sport

Slovenia

INSTITUTO DE SALUD CARLOS III

Spain

EU Contribution

€ 138 386

CANCER RESEARCH UK LBG

United Kingdom

EU Contribution

€ 111 012

TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU

Turkey

EU Contribution

€ 20 062

FONDATION ARC POUR LA RECHERCHE SUR LE CANCER

France

EU Contribution

€ 6 500

Kreftforeningen

Norway

EU Contribution

€ 6 500

STICHTING KONINGIN WILHELMINA FONDS VOOR DE NEDERLANDSE KANKERBESTRIJDING

Netherlands

EU Contribution

€ 6 675

Project information

Grant agreement ID: 266559

Status

Closed project

  • Start date

    1 January 2011

  • End date

    31 December 2014

Funded under:

FP7-HEALTH

  • Overall budget:

    € 2 415 483,86

  • EU contribution

    € 1 999 956

Coordinated by:

MINISTERO DELLA SALUTE

Italy